HUB Organoids
Pre-clinicalA PATIENT IN THE LAB® HUB Organoids predict patient response to treatment. Our patented technology allows the development of patient-derived “mini-organs in a dish” from both healthy and diseased tissues to close the gap between the lab and the clinic.
Founded
2013
Focus
OrganoidsDrug Discovery
About
A PATIENT IN THE LAB® HUB Organoids predict patient response to treatment. Our patented technology allows the development of patient-derived “mini-organs in a dish” from both healthy and diseased tissues to close the gap between the lab and the clinic.
Funding History
2Total raised: $19.5M
Series A$16MKIKK CapitalSep 15, 2021
Seed$3.5MLife Sciences PartnersJun 15, 2019
Company Info
TypePrivate
Founded2013
LocationUtrecht, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile